Use of Prescribed Drugs to Treat Chronic Diseases during Pregnancy in Outpatient Care in Switzerland between 2014 and 2018: Descriptive Analysis of Swiss Health Care Claims Data.

导出 OA

翻译打印收藏纠错

作者： Eva,Gerbier ^[1] ; Sereina M,Graber ^[2] ; Marlene,Rauch ^[3] ; Carole A,Marxer ^[3] ; Christoph R,Meier ^[3] ; David,Baud ^[4] ; Ursula,Winterfeld ^[5] ; Eva,Blozik ^[6] ; Daniel,Surbek ^[7] ; Julia,Spoendlin ^[3] ; Alice,Panchaud ^[1]

作者单位： Service of Pharmacy, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.;Institute of Primary Health Care (BIHAM), University of Bern, 3012 Bern, Switzerland. ^[1] Department of Health Sciences, Helsana Insurance Group, 8001 Zurich, Switzerland. ^[2] Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, 4031 Basel, Switzerland.;Hospital Pharmacy, University Hospital Basel, 4056 Basel, Switzerland. ^[3] Materno-Fetal and Obstetrics Research Unit, Department "Woman-Mother-Child", Lausanne University Hospital, 1011 Lausanne, Switzerland. ^[4] Swiss Teratogen Information Service and Clinical Pharmacology Service, Lausanne University Hospital, 1011 Lausanne, Switzerland. ^[5] Department of Health Sciences, Helsana Insurance Group, 8001 Zurich, Switzerland.;Institute of Primary Care, University Hospital of Zurich, 8091 Zurich, Switzerland. ^[6] Department of Obstetrics and Gynaecology, Bern University Hospital, Insel Hospital, University of Bern, 3010 Bern, Switzerland. ^[7]

关键词 chronic diseases claims database drug utilisation electronic database fetotoxic pregnancy teratogenic